Document is current
Any future updates will be listed below
-
Authors
Muthmainah, Muthmainah
Sketriene, Diana
Anversa, Roberta G.
Harris, Emily
Griffiths, Scott
Gogos, Andrea
Sumithran, Priya
Brown, Robyn M. https://orcid.org/0000-0003-4167-3634
-
Funding
Funding for this research was provided by:
University of Melbourne
- License Information
-
More Information
Article History
Received: 9 October 2023
Accepted: 21 January 2025
First Online: 19 February 2025
Declarations
:
: This study has been prospectively registered with the Australian and New Zealand Clinical Trials Registry (Trial registration: ACTRN12622000902796) and approved by the University of Melbourne human research ethics committee (HREC), Reference Number: 2022–22812-35644–8. This study will be conducted in compliance with Australia’s National Statement on Ethical Conduct in Human Research. Any change to the protocol document or informed consent form that affects the scientific intent, study design, or participant safety will be submitted to the HREC for approval prior to being implemented. Institutional governance authorisation for the research and associated HREC-approved documents is provided by the Florey Institute of Neuroscience and Mental Health. Participants will be required to provide written informed consent to participate in the study.
: Not applicable.
: PS has co-authored manuscripts with medical writing assistance provided by Novo Nordisk and Eli Lilly. The other authors declare no conflicts of interest.
